| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Molecular Epidemiology Unit, Centre for Epidemiology and Biostatistics, Faculty of Medicine and Health; 2 Academic Unit of General Surgery, Medicine and Anaesthesia, School of Medicine, University of Leeds; 3 Gastroenterology Unit and 4 Department of Radiology, Leeds General Infirmary, Leeds, United Kingdom
Requests for reprints: Christopher Wild, Molecular Epidemiology Unit, Centre for Epidemiology and Biostatistics, Faculty of Medicine and Health, LIGHT Laboratories, University of Leeds, Leeds LS2 9JT, United Kingdom. Phone: 44-113-3436602; Fax: 44-113-3436603. E-mail: c.p.wild{at}leeds.ac.uk
Esophageal adenocarcinoma develops on a background of Barrett's esophagus. A number of risk factors have been linked to both conditions, including gastroesophageal reflux and smoking. However, the molecular mechanisms by which these factors influence disease progression remain unclear. One possibility is that risk factors generate promutagenic DNA damage in the esophagus. The comet assay was used to measure DNA damage in esophageal (Barrett's and squamous) and gastric mucosa of Barrett's patients with (n = 24) or without (n = 50) associated adenocarcinoma or high-grade dysplasia in comparison with control patients (squamous mucosa) without Barrett's esophagus (n = 64). Patients completed a questionnaire detailing exposure to some of the known risk factors for Barrett's esophagus and adenocarcinoma. In Barrett's esophagus patients, DNA damage was higher in Barrett's mucosa compared with normal esophageal and gastric mucosa (P < 0.001). In addition, the highest quartile of DNA damage in Barrett's mucosa was associated with an increased risk (odds ratio, 9.4; 95% confidence interval, 1.1-83.4; P = 0.044) of developing adenocarcinoma or high-grade dysplasia compared with DNA damage levels in the lowest quartile. Smoking was associated with higher DNA damage in squamous epithelium in all patient groups (P < 0.01) and in Barrett's mucosa (P < 0.05) in Barrett's esophagus patients only. In controls only, current reflux was associated with higher DNA damage, whereas anti-inflammatory drug use resulted in lower levels. Collectively, these data imply a genotoxic insult to the premalignant Barrett's mucosa that may explain the genetic instability in this tissue and the progression to adenocarcinoma. There is an indication for a role for smoking in inducing DNA damage in esophageal mucosa but an understanding of the role of reflux requires further investigation.
This article has been cited by other articles:
|
|
 |
|
  J. Pan, J. Lin, J. G. Izzo, Y. Liu, J. Xing, M. Huang, J. A. Ajani, and X. Wu Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway Carcinogenesis, May 1, 2009; 30(5): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. McKenna, S. R. McKeown, and V. J. McKelvey-Martin Potential use of the comet assay in the clinical management of cancer Mutagenesis, May 1, 2008; 23(3): 183 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Reddy Thavanati, K. R. Kanala, A. E. de Dios, and J. M. Cantu Garza Age-Related Correlation Between Antioxidant Enzymes and DNA Damage With Smoking and Body Mass Index J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2008; 63(4): 360 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Y. Zhang, X. Zhang, K. Hormi-Carver, L. A. Feagins, S. J. Spechler, and R. F. Souza In Non-neoplastic Barrett's Epithelial Cells, Acid Exerts Early Antiproliferative Effects through Activation of the Chk2 Pathway Cancer Res., September 15, 2007; 67(18): 8580 - 8587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R C Fitzgerald Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, December 1, 2006; 55(12): 1810 - 1820. [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Chao, C. C. Maley, X. Wu, D. C. Farrow, P. C. Galipeau, C. A. Sanchez, T. G. Paulson, P. S. Rabinovitch, B. J. Reid, M. R. Spitz, et al. Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1935 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Murray, A Sedo, M Scott, D McManus, J M Sloan, L J Hardie, D Forman, and C P Wild TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort Gut, October 1, 2006; 55(10): 1390 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hoffmann, J. Hogel, and G. Speit The effect of smoking on DNA effects in the comet assay: a meta-analysis Mutagenesis, November 1, 2005; 20(6): 455 - 466. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
